Loading...

Immune Checkpoint Inhibition in Classical Hodgkin Lymphoma: From Early Achievements towards New Perspectives

Immune checkpoint inhibition (ICI) became one of the major breakthroughs in cancer treatment over the past decade and entered into therapy within standard oncohematology practice. ICI has demonstrated impressive response rates as salvage therapy in relapsed/refractory (R/R) classical Hodgkin lymphom...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Oncol
Main Authors: De Goycoechea, Diego, Stalder, Gregoire, Martins, Filipe, Duchosal, Michel A.
Format: Artigo
Sprog:Inglês
Udgivet: Hindawi 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6530161/
https://ncbi.nlm.nih.gov/pubmed/31205470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/9513701
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!